Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020
Published: 21 September 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:
Journal of Neuromuscular Diseases: Volume 7, issue 4
*Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.
Articles in this issue:
- Towards central nervous system involvement in adults with hereditary myopathies
- Induction of skeletal muscle progenitors and stem cells from human induced pluripotent stem cells
- Lower extremity muscle involvement in the intermediate and Bethlem myopathy forms of COL6-related dystrophy and Duchenne muscular dystrophy: A cross-sectional study
- Ganglionopathies associated with MERRF syndrome: An original report
- Respiratory dysfunction in Becker muscular dystrophy patients: A case series and autopsy report
- Decision-making and selection bias in four observational studies on Duchenne and Becker muscular dystrophy
- Phenotypic spectrum of myopathies with recessive anoctamin-5 mutations
- Natural history of type 1 spinal muscular atrophy in a series of Argentinian children
- Neuroanatomical models of muscle strength and relationship to ambulatory function in spinal muscular atrophy
- Facilitators and barriers to wearing hand orthoses by adults with Duchenne muscular dystrophy: A mixed methods study design
- Identification and characterization of splicing defects by single-molecule real-time sequencing technology (PacBio)
- Swallowing, chewing, and speaking: Frequently impaired in oculopharyngeal muscular dystrophy
- Correlation between quantitative MRI and muscle histopathology in muscle biopsies from healthy controls and patients with IBM, FSHD, and OPMD
- A new point mutation in the PMP22 gene in a family suffering from atypical HNPP
- Severe inflammatory myopathy in a pulmonary carcinoma patient treated with Pembrolizumab: An alert for myologists
- Familial oculo-leptomeningeal transthyretin amyloidosis caused by Leu55Arg mutation
- Taking a Strohl through history: Putting Strohl back in Guillain-Barré-Strohl syndrome
- Measuring outcomes in adults with spinal muscular atrophy: Challenges and future directions – Meeting report
Read next...
Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine
We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice
Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...
Celebrating Lab Members’ Recent Research Awards
We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
Meet The Lochmüller Lab’s Newest Members!
Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort
Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses
Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...